Trials / Completed
CompletedNCT03242083
Evaluate the Quality of Life of Patients With AMD
Evaluation de la Quality of Life in Secondary Atrophic Age-related Macular Degeneration
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Age-related macular degeneration (AMD) is a major cause of deep visual acuity loss. Because of progressive deterioration of the macula, patients with AMD complain about progressive visual problems that can impair their quality of life in the physical, mental and social domains. The principal objective principal of this study is to describe the evolution of quality of life between the diagnosis of secondary atrophic AMD and at 18 months after confirmation of diagnosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | quality of life questionnaire | quality of life questionnaire |
Timeline
- Start date
- 2017-08-08
- Primary completion
- 2019-12-03
- Completion
- 2019-12-03
- First posted
- 2017-08-08
- Last updated
- 2020-01-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03242083. Inclusion in this directory is not an endorsement.